DODGE & COX - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
DODGE & COX ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$371,680,163
+171181.2%
9,848,441
+291101.7%
0.25%
Q2 2022$217,000
-17.2%
3,3820.0%0.00%
Q1 2022$262,000
-9.7%
3,3820.0%0.00%
Q4 2021$290,000
-4.6%
3,382
-10.6%
0.00%
Q3 2021$304,0000.0%3,7820.0%0.00%
Q2 2021$304,000
+6.7%
3,782
+11.8%
0.00%
Q1 2021$285,000
+5.2%
3,3820.0%0.00%
Q4 2020$271,000
-0.4%
3,3820.0%0.00%
Q3 2020$272,000
-6.5%
3,3820.0%0.00%
Q2 2020$291,000
+5.8%
3,3820.0%0.00%
Q1 2020$275,000
-2.8%
3,3820.0%0.00%
Q4 2019$283,000
-4.4%
3,3820.0%0.00%
Q3 2019$296,000
+6.9%
3,3820.0%0.00%
Q2 2019$277,000
+0.7%
3,3820.0%0.00%
Q1 2019$275,000
+23.3%
3,3820.0%0.00%
Q4 2018$223,000
-14.6%
3,3820.0%0.00%
Q3 2018$261,000
+4.4%
3,3820.0%0.00%
Q2 2018$250,000
+13.6%
3,3820.0%0.00%
Q1 2018$220,000
+0.5%
3,3820.0%0.00%
Q4 2017$219,000
+3.3%
3,3820.0%0.00%
Q3 2017$212,000
+3.4%
3,3820.0%0.00%
Q2 2017$205,000
-13.5%
3,3820.0%0.00%
Q2 2015$237,000
+2.2%
3,3820.0%0.00%
Q1 2015$232,000
-6.5%
3,3820.0%0.00%
Q4 2014$248,000
+2.1%
3,3820.0%0.00%
Q3 2014$243,000
-0.8%
3,3820.0%0.00%
Q2 2014$245,000
-2.0%
3,382
-0.6%
0.00%
Q1 2014$250,000
+6.4%
3,404
+0.7%
0.00%
Q4 2013$235,000
+5.9%
3,3820.0%0.00%
Q3 2013$222,000
-10.5%
3,382
-5.6%
0.00%
Q2 2013$248,0003,5820.00%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders